Macrogenics reported $271.44M in Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Abbvie ABBV:US $ 143211M 3318M
Amgen AMGN:US $ 59196M 1969M
AstraZeneca AZN:LN 100273M 5090M
Biogen BIIB:US $ 23614.4M 262.9M
Bristol Myers Squibb BMY:US $ 103034M 6280M
Cerulean Pharma CERU:US $ 49.19M 6.62M
Daiichi Sankyo 4568:JP Y 2221402M 57930M
Eli Lilly And LLY:US $ 46919.3M 1886.7M
Epizyme EPZM:US $ 312.19M 23.19M
Genmab GEN:DC DK 24914M 287M
Geron GERN:US $ 198.42M 27.61M
Gilead Sciences GILD:US $ 63080M 4872M
Immunogen IMGN:US $ 481.71M 44.06M
Johnson & Johnson JNJ:US $ 178355M 3663M
Karyopharm Therapeutics KPTI:US $ 294.03M 11.27M
Macrogenics MGNX:US $ 271.44M 63.8M
Merk MRK:US $ 106668M 974M
Mirati Therapeutics MRTX:US $ 1421.3M 167.46M
Puma Biotechnology PBYI:US $ 200.68M 25.9M
Regeneron Pharmaceuticals REGN:US $ 26348.7M 913.9M
Seattle Genetics SGEN:US $ 3616.69M 102.91M
Xencor XNCR:US $ 857.92M 19.71M